SE8405501L - Partikelformat diagnosticeringsmedel - Google Patents

Partikelformat diagnosticeringsmedel

Info

Publication number
SE8405501L
SE8405501L SE8405501A SE8405501A SE8405501L SE 8405501 L SE8405501 L SE 8405501L SE 8405501 A SE8405501 A SE 8405501A SE 8405501 A SE8405501 A SE 8405501A SE 8405501 L SE8405501 L SE 8405501L
Authority
SE
Sweden
Prior art keywords
insoluble
water
diagnosticing
agent
particle size
Prior art date
Application number
SE8405501A
Other languages
English (en)
Other versions
SE465909B (sv
SE8405501D0 (sv
Inventor
T Jacobson
Original Assignee
Nyegaard & Co As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nyegaard & Co As filed Critical Nyegaard & Co As
Priority to SE8405501A priority Critical patent/SE465909B/sv
Publication of SE8405501D0 publication Critical patent/SE8405501D0/sv
Priority to DE8585307738T priority patent/DE3577185D1/de
Priority to EP85307738A priority patent/EP0184899B1/en
Priority to AT85307738T priority patent/ATE52032T1/de
Priority to DK500085A priority patent/DK164486C/da
Priority to NO854349A priority patent/NO169525C/no
Priority to US06/793,899 priority patent/US4985233A/en
Priority to JP60244240A priority patent/JPH0678246B2/ja
Publication of SE8405501L publication Critical patent/SE8405501L/sv
Publication of SE465909B publication Critical patent/SE465909B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
    • A61K49/1806—Suspensions, emulsions, colloids, dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
    • A61K49/1818—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles
    • A61K49/1821—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles
    • A61K49/1824—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles
    • A61K49/1827—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle
    • A61K49/1851—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle having a (super)(para)magnetic core coated or functionalised with an organic macromolecular compound, i.e. oligomeric, polymeric, dendrimeric organic molecule
    • A61K49/1863—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle having a (super)(para)magnetic core coated or functionalised with an organic macromolecular compound, i.e. oligomeric, polymeric, dendrimeric organic molecule the organic macromolecular compound being a polysaccharide or derivative thereof, e.g. chitosan, chitin, cellulose, pectin, starch

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Nanotechnology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
SE8405501A 1984-11-01 1984-11-01 Partikelformat diagnosticeringsmedel innehaallande en paramagnetisk metall SE465909B (sv)

Priority Applications (8)

Application Number Priority Date Filing Date Title
SE8405501A SE465909B (sv) 1984-11-01 1984-11-01 Partikelformat diagnosticeringsmedel innehaallande en paramagnetisk metall
DE8585307738T DE3577185D1 (de) 1984-11-01 1985-10-25 Paramagnetische kontrastmittel fuer die anwendung in "in vivo" nmr-diagnostischen methoden und die herstellung davon.
EP85307738A EP0184899B1 (en) 1984-11-01 1985-10-25 Paramagnetic contrast agents for use in "in vivo" diagnostic methods using nmr, and their preparation
AT85307738T ATE52032T1 (de) 1984-11-01 1985-10-25 Paramagnetische kontrastmittel fuer die anwendung in ''in vivo'' nmr-diagnostischen methoden und die herstellung davon.
DK500085A DK164486C (da) 1984-11-01 1985-10-31 Diagnostisk middel indeholdende en ikke-radioaktiv paramagnetisk metalspecies og anvendelse heraf til fremstilling af et middel til brug ved nmr- og ultralydsdiagnostik
NO854349A NO169525C (no) 1984-11-01 1985-10-31 Diagnostisk preparat
US06/793,899 US4985233A (en) 1984-11-01 1985-11-01 A diagnostic agent containing a non-radioactive paramagnetic metal species in a macromolecular carrier
JP60244240A JPH0678246B2 (ja) 1984-11-01 1985-11-01 診断用組成物

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8405501A SE465909B (sv) 1984-11-01 1984-11-01 Partikelformat diagnosticeringsmedel innehaallande en paramagnetisk metall

Publications (3)

Publication Number Publication Date
SE8405501D0 SE8405501D0 (sv) 1984-11-01
SE8405501L true SE8405501L (sv) 1986-05-02
SE465909B SE465909B (sv) 1991-11-18

Family

ID=20357594

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8405501A SE465909B (sv) 1984-11-01 1984-11-01 Partikelformat diagnosticeringsmedel innehaallande en paramagnetisk metall

Country Status (1)

Country Link
SE (1) SE465909B (sv)

Also Published As

Publication number Publication date
SE465909B (sv) 1991-11-18
SE8405501D0 (sv) 1984-11-01

Similar Documents

Publication Publication Date Title
ATE54416T1 (de) Paramagnetische kontrastmittel fuer die anwendung in ''in vivo'' nmr-diagnostischen methoden und die herstellung davon.
ATE151294T1 (de) Wasserunlösliche hyaluronsäureabkömmlinge
AU6786187A (en) Pharmaceutical preparation for obtaining a highly viscose hydrogel or suspension
ATE138940T1 (de) Wasserlösliche hyaluronsäurederivate
ES2096728T3 (es) Procedimiento para reconstitucion de tabaco.
DK1042339T3 (da) Carbohydrater, der er egnede i faste administrationssystemer
JPS5758615A (en) Film agnent and its preparation
DE69803940D1 (de) Ophthalmische zusammensetzungen mit verlängerte freisetzung enthaltend im wasser lösliche arzneistoffe
CA2158689A1 (en) Medical devices containing triggerable disintegration agents
ZA796683B (en) A pharmaceutical preparation comprising a cardiac glycoside in combination with a polymer
ES425292A1 (es) Cateter no trombogenico.
ZA812088B (en) Derivative of saccharide and physiologically active agent containing the same
ZA773430B (en) Aqueous compositions comprising phenolic resin and cross linking agent
GB1252200A (sv)
SE8405501L (sv) Partikelformat diagnosticeringsmedel
GB2219588B (en) Polysaccharides containing betaine groups and having recurring anhydroglucose units,their preparation and their use in cosmetic formulations
DE3264331D1 (en) Aqueous preparation and its use in the preparation of ceramic masses
SE8405500D0 (sv) Diagnostic particles
SE7900738L (sv) Farmaceutiskt medel
JPS579711A (en) Preparation of prolonged release type complex
AU9107382A (en) Sodium cromoglycate and water insoluble hydrophilic macromolecular material
ES517977A0 (es) Procedimiento para la preparacion de una solucion que contiene glucosa y fructosa.
GB1518813A (en) Diagnostic agent
IT1190782B (it) Derivati diossazabiciclici,loro procedimento di preparazione e loro applicazione in terapia
ES375202A1 (es) Procedimiento para preparar un extracto de una sustancia activa capaz de producir una respuesta alergenica y que con- tiene principio fisiologicos activos.

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8405501-1

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 8405501-1

Format of ref document f/p: F